8-K - BridgeBio Pharma Inc. | Modeledge

BridgeBio Pharma Inc.

Filing type: 8-K
Filing date: Jul 1, 2026
Updated: Jul 2, 2026 · 2:26 PM

Filing

8-KMaterial Contracts, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD

Exhibits

EX-3.1EXHIBIT 3.1 EX-10.1EXHIBIT 10.1 EX-10.2EXHIBIT 10.2 EX-99.1Material Contracts, Unregistered Sales of Equity Securities, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD GRAPHIC GRAPHIC GRAPHIC